Skip to main content
Clinical Trials/NCT02652533
NCT02652533
Completed
Not Applicable

Ultrasound Shear Wave Elastography Evaluation of Suspected and Known Biliary Atresia

Children's Hospital Medical Center, Cincinnati4 sites in 1 country41 target enrollmentSeptember 2016
ConditionsBiliary Atresia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Biliary Atresia
Sponsor
Children's Hospital Medical Center, Cincinnati
Enrollment
41
Locations
4
Primary Endpoint
Discrimination of biliary atresia from other liver diseases using ultrasound liver shear wave speed (Aim 1)
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

The investigators plan to investigate the use of US shear wave elastography (SWE), a newly available imaging technology, in children with suspected/known BA.

Detailed Description

The investigators plan a prospective, multi-center study to determine if liver ultrasound shear wave speed measurements acquired at clinical presentation can discriminate biliary atresia (BA) from other causes of liver disease in the setting of neonatal cholestasis. The investigators also plan to determine if liver ultrasound shear wave speed measurements acquired at clinical presentation or longitudinally during the first one-year period after Kasai can predict important long-term outcomes in BA patients.

Registry
clinicaltrials.gov
Start Date
September 2016
End Date
July 2019
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • neonatal cholestasis with concern for BA vs. other liver disease direct bilirubin \>20% of total or ≥2 mg/dL age \<3 months

Exclusion Criteria

  • inability to obtain parent/guardian consent.
  • inability to return for follow up visits as required by the study (these patients will be included in aim 1, but will be unable to participate in aim 2).
  • no other exclusion criteria.

Outcomes

Primary Outcomes

Discrimination of biliary atresia from other liver diseases using ultrasound liver shear wave speed (Aim 1)

Time Frame: 2 years

The primary outcome measure will be ultrasound shear wave speed of the liver. The investigators will compare the mean liver shear wave speed measurements in children with biliary atresia to other liver diseases. Sensitivity and specificity of ultrasound for diagnosing biliary atresia will be determined using multiple shear wave speed cut-off values.

Secondary Outcomes

  • Predicting long term clinical outcomes in biliary atresia patients using ultrasound liver shear wave speed (aim 2)(6 years)

Study Sites (4)

Loading locations...

Similar Trials